News

The latest news about Fore and our treatments
FORE BIOTHERAPEUTICS ANNOUNCES FAST TRACK DESIGNATION GRANTED BY FDA TO FORE8394 FOR THE TREATMENT OF CANCERS HARBORING BRAF CLASS 1 AND CLASS 2 ALTERATIONS Read more